Clinical and Histological Indicators of Proximal and Distal Gastric Cancer in Eight Provinces of Iran |
Norouzinia, M.
(Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Science)
Asadzadeh, H. (Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Science) Shalmani, H. Mohaghegh (Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Science) Al Dulaimi, D. (Department of Gastroenterology Alexander Hospital Redditch) Zali, M.R. (Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Science) |
1 | Bornschein J, Rokkas T, Selgrad M, Malfertheiner P (2011). Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter, 16, 45-52. DOI |
2 | Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents, Vol. IX. |
3 | Dos Santos Silva IS (1999). Cancer Epidemiology: Principles and Methods. Int Agency for Res Cancer, Lyon, France, 70-6. |
4 | Ekstrom AM, Hansson LE, Signorello LB, Lindgren A, Bergstrom R, Nyren O (2000). Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. Br J Cancer, 83, 391-6. DOI ScienceOn |
5 | Eriksson NK, Karkkainen PA, Farkkila MA, Arkkila PE (2008). Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis, 40, 355-60. DOI |
6 | Gonzalez CA, Lopez-Carrillo L (2010). Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol, 45, 6-14. DOI |
7 | Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. DOI |
8 | Koh TJ, Wang TC (2002).Tumors of the Stomach. In: Feldman M, Friedman LS, Sleisenger MH. Gastrointestinal and Liver Disease.7th edition. USA. SAUNDERS, 829. |
9 | Liu L, Wang ZW, Ji J, et al (2012). A cohort study and metaanalysis between histopathological classification and prognosis of gastric carcinoma. Anticancer Agents Med Chem, 2012 Aug 24. [Epub ahead of print] PubMed PMID:22934699. |
10 | Moghimi-Dehkordi B, Safaee A, Vahedi M, et al (2012). History of upper gastrointestinal cancers in relatives: a communitybased estimate. Gastroenterol Hepatol Bed Bench, 5, 100-5. |
11 | Nyren O, Adami HO (2002). Stomach cancer in: hans-olov adami, david hunter, dimitrios trichopoulos. textbook of cancer epidemiology. USA: Oxford University Press, 162-87. |
12 | Patel SH, Kooby DA (2011). Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am, 91, 1039-77. DOI |
13 | Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Abadi AR (2010). Bayesian analysis of gastric cancer mortality in Iranian population. Gastroenterol Hepatol Bed Bench, 3, 15-18. |
14 | Rostami M, Kadivar M, Aznab M, Abachi M (2012). Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran. Gastroenterol Hepatol Bed Bench, 5, 29-34. |
15 | Vieth M, Stolte M (2005). Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol, 19, 857-69. DOI |
16 | Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8. DOI |
17 | Sipponen P (2002). Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol, 37, 39-44. DOI ScienceOn |
18 | Yeoh KG (2007). How do we improve outcomes for gastric cancer? J Gastroenterol Hepatol, 22, 970-2. DOI |
19 | Zali H, Rezaei-Tavirani M, Azodi M (2011). Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench, 4, 175-85 |
![]() |